Nu-Med Plus, Inc. NUMD
Surgical & Medical Instruments & Apparatus · CIK 0001543637 · Fiscal year ends 1231
Revenue
$0
Fiscal year ended 2020-12-31Operating income
-$1.99M
Fiscal year ended 2020-12-31Free cash flow
—Unavailable
Fiscal year ended 2020-12-31Valuation, from the filing
| Public float | $3.24M | Market value of stock held by non-affiliates, as stated on the cover page for 2025-06-30 |
|---|
| Float per share | $0.04 | Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself. |
|---|
Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today.
How this compares in its industry
Percentile among the Surgical & Medical Instruments & Apparatus filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.
Nu-Med Plus, Inc. (NUMD) reported revenue of $0 and net income of -$2.01M for the fiscal year ended 2020-12-31. This page shows 7 annual periods of income statement, balance sheet and cash flow figures normalized from Nu-Med Plus, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.
Income
Nu-Med Plus, Inc. income by fiscal year, in US dollars, normalized from SEC filings.| Metric | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
|---|
| Cost of revenue | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
| Gross profit | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
| Operating income | -$1.99M | -$1.02M | -$1.17M | -$466.52K | -$1.22M | -$946.48K | -$1.15M |
|---|
| Net income | -$2.01M | -$1.04M | -$1.19M | $3.58M | $9.65M | -$8.88M | -$1.19M |
|---|
| Research & development | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
| Weighted-average diluted shares | shares 54.51M | shares 45.55M | shares 41.79M | shares 71.86M | shares 75.03M | shares 35.40M | —Unavailable |
|---|
| Pretax income | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
| Income tax expense | $0 | $0 | $100 | $0 | $0 | $0 | $0 |
|---|
| Diluted EPS | $-0.04 | $-0.02 | $-0.03 | $0.05 | $0.13 | $-0.25 | —Unavailable |
|---|
| Selling, general & administrative | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
| General & administrative | $58.26K | $76.13K | $128.10K | $64.96K | $62.17K | $34.88K | $60.17K |
|---|
| Selling & marketing | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
Balance
Nu-Med Plus, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.| Metric | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
|---|
| Cash & equivalents | $188.51K | $7.08K | $167.51K | $351.04K | $12.45K | $30.90K | $56.27K |
|---|
| Total assets | $557.14K | $45.78K | $423.02K | $406.72K | $35.53K | $75.94K | $213.06K |
|---|
| Current assets | $537.52K | $13.96K | $386.22K | $360.21K | $12.45K | $45.72K | $172.12K |
|---|
| Total liabilities | $89.43K | $416.21K | $374.49K | $338.48K | $4.47M | —Unavailable | —Unavailable |
|---|
| Current liabilities | $80.05K | $416.21K | $374.49K | $327.91K | $4.47M | $15.30M | $266.83K |
|---|
| Total equity incl. NCI | $467.70K | -$370.43K | $48.53K | $68.24K | -$4.44M | -$15.22M | -$7.11M |
|---|
| Temporary (mezzanine) equity | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
| Inventory | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
| Accounts receivable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
| Goodwill | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
| Long-term debt | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
| Accounts payable | $26.05K | $39.82K | $9.78K | $0 | $5.06K | $6.40K | $0 |
|---|
Cash flow
Derived
Nu-Med Plus, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.| Metric | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
|---|
| Free cash flow | —Unavailable | —Unavailable | —Unavailable | -$430.51K | —Unavailable | —Unavailable | —Unavailable |
|---|
| Gross margin | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
| Operating margin | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
| FCF margin | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
| SBC / revenue | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
| Current ratio | 6.72x | 0.03x | 1.03x | 1.10x | 0.00x | 0.00x | 0.65x |
|---|
| Revenue YoY growth | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
| Net margin | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
| R&D / revenue | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
| CapEx / revenue | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
| Long-term debt / equity | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
| Effective tax rate | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open NUMD in the interactive workspace to inspect any figure back to its filing.
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.